All Articles

A new documentary on a Silicon Valley engineer turned cricket hero reveals a calculated strategy: to win America's heart, you must first tell its stories.

The new collaboration embeds S&P Global's essential data into Cohere's secure AI platform, promising verifiable, agentic workflows for Wall Street.

A Canadian upstart is poised to unlock a massive, untreated market by moving glaucoma surgery from the OR to the office. This isn't just a new device; it's a strategic dismantling of a decades-old bottleneck.

A digital health firm is trading millions in shares for a spot on the racetrack. A deep dive into the high-octane strategy to solve healthcare access.

The promotion of Tony Pallas to CTO is no mere shuffle. It's a calculated move to arm thousands of franchisees with AI, signaling a new front in the war for hospitality tech dominance.

As travel habits shift, new business models and government incentives are making Canada's waterways more accessible than ever, fueling a multi-billion dollar industry.

A new report reveals a dangerous disconnect: while AI accelerates coding, 95% of CISOs are pressured to ignore the security flaws it creates.

Melcor Developments is betting on itself with a massive share buyback. Is it a savvy move to exploit an undervalued stock or a bold signal of confidence?

Good Grains' nationwide launch in Sprouts isn't just another product release. It's a signal of the food industry's pivot toward transparency and resilience.

Hilton Hawaiian Village's legendary Rainbow Tower gets a modern, art-infused refresh, blending 65 years of history with a strategic vision for the future.

As return-to-office mandates clash with the needs of 5 million Canadians with migraine, the economic toll of inaction is mounting for employers.

The AvalonBay-Equity merger just named its leaders. It's not just a new C-suite; it's a blueprint for a tech-driven, $69B titan set on dominating the rental market.

A new campaign frames fusion energy as a U.S.-China security race. But beyond the hype, what is the reality of the global push for limitless power?

Dr. Brian Covino's top honor signals a shift in health tech, where AI doesn't replace doctors but learns from them. Can this model fix our broken system?

Septerna's novel oral drug for hypoparathyroidism could end the tyranny of injections and supplements, but its success hinges on a bigger bet: a new system for drugging life's most difficult molecular targets.

BioCardia secures a crucial $4.4M, extending its runway for a key Japan submission. But a closer look reveals a high-stakes bet on future warrant exercises.

A tech firm with a history of pivots, Mitesco is launching an AI real estate tool. Can its unique strategy of deep industry collaboration overcome financial headwinds?

New research shows 'Food is Medicine' programs thrive when paired with human coaching, offering a potent, scalable model for tackling chronic disease.

A new alliance between tech firm Seequent and think tank Cascade Institute aims to map Canada's vast, untapped geothermal reserves using novel AI.

K-beauty leader Rael disrupts the U.S. market with advanced hydrogel masks and the first Korean-made tampon, pioneering a new era of 'K-Wellness'.